Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article First patient in Quebec gets approval from Health Canada for magic mushroom therapy

First patient in Quebec gets approval from Health Canada for magic mushroom therapy

  • Post author:Olly PP
  • Post published:May 17, 2022
  • Post category:Industry News

Continue ReadingFirst patient in Quebec gets approval from Health Canada for magic mushroom therapy
Read more about the article We cannot meet the mental health needs of cancer patients without breaking down silos

We cannot meet the mental health needs of cancer patients without breaking down silos

  • Post author:Olly PP
  • Post published:April 29, 2022
  • Post category:Industry News

Continue ReadingWe cannot meet the mental health needs of cancer patients without breaking down silos
Read more about the article The Mission to Make Psilocybin Available to UK Cancer Patients

The Mission to Make Psilocybin Available to UK Cancer Patients

  • Post author:Olly PP
  • Post published:April 25, 2022
  • Post category:News

Continue ReadingThe Mission to Make Psilocybin Available to UK Cancer Patients
Read more about the article Psilocybin Could be a Therapeutic Breakthrough For Addiction

Psilocybin Could be a Therapeutic Breakthrough For Addiction

  • Post author:Olly PP
  • Post published:April 19, 2022
  • Post category:Industry News

Continue ReadingPsilocybin Could be a Therapeutic Breakthrough For Addiction
Read more about the article Psychedelic frees up depressed brain, study shows

Psychedelic frees up depressed brain, study shows

  • Post author:Olly PP
  • Post published:April 11, 2022
  • Post category:Industry News

Continue ReadingPsychedelic frees up depressed brain, study shows
Read more about the article 6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules

6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules

  • Post author:Olly PP
  • Post published:April 7, 2022
  • Post category:Industry News

Continue Reading6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules
Read more about the article Psychedelics may ease cancer patients’ depression, anxiety

Psychedelics may ease cancer patients’ depression, anxiety

  • Post author:Olly PP
  • Post published:April 2, 2022
  • Post category:Industry News

Continue ReadingPsychedelics may ease cancer patients’ depression, anxiety
Read more about the article The Promise of Psychedelics for Health and Health Behaviors

The Promise of Psychedelics for Health and Health Behaviors

  • Post author:Olly PP
  • Post published:March 29, 2022
  • Post category:Industry News

Continue ReadingThe Promise of Psychedelics for Health and Health Behaviors
Read more about the article What do psychedelic drugs do to our brains? AI could help us find out

What do psychedelic drugs do to our brains? AI could help us find out

  • Post author:Olly PP
  • Post published:March 16, 2022
  • Post category:Industry News

Continue ReadingWhat do psychedelic drugs do to our brains? AI could help us find out
Read more about the article Is the UK Becoming a Global Center for Psychedelic Medicine?

Is the UK Becoming a Global Center for Psychedelic Medicine?

  • Post author:Olly PP
  • Post published:March 15, 2022
  • Post category:News

Continue ReadingIs the UK Becoming a Global Center for Psychedelic Medicine?
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors
  • Albert Labs Management and Board of Director Announcement
  • Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement

Recent Comments

  • Randal Elliott on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Nicholas Stewart on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Camille Ortega on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Kelly Lambert on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Dean Phillips on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.